Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

BACKGROUND: The efficacy of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) remains unclear. We conducted a multi-center randomized phase II study comparing a sequential HAIC-sorafenib regimen versus sorafenib alone as an initial therapy for HCC. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Masaaki, Morimoto, Manabu, Kobayashi, Satoshi, Ohkawa, Shinichi, Hidaka, Hisashi, Nakazawa, Takahide, Aikata, Hiroshi, Hatanaka, Takeshi, Takizawa, Daichi, Matsunaga, Kotaro, Okuse, Chiaki, Suzuki, Michihiro, Taguri, Masataka, Ishibashi, Takako, Numata, Kazushi, Maeda, Shin, Tanaka, Katsuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794885/
https://www.ncbi.nlm.nih.gov/pubmed/31615466
http://dx.doi.org/10.1186/s12885-019-6198-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794885/
https://www.ncbi.nlm.nih.gov/pubmed/31615466
http://dx.doi.org/10.1186/s12885-019-6198-8

Ejemplares similares